Clinical Trial Update: Safety and Efficacy of Cellcept and Avonex as Combination Treatment in Multiple Sclerosis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the safety and efficacy of combining Cellcept (mycophenolate mofetil) with Avonex (interferon beta-1a) for multiple sclerosis has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Avonex (Interferon beta-1a)
• CELLCEPT (mycophenolate mofetil hydrochloride)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Multiple Sclerosis | Phase 2 | Status: COMPLETED